Summary Overt liver tumour was induced in Fisher rats by intraportal administration of 1.6 x 107 Walker carcinosarcoma cells. Control groups of rats received similar volumes of dead cells or saline intraportally. All animals were studied at 3 weeks when overt tumour was present. The Hepatic Perfusion Index (HPI) was significantly raised in rats with overt tumour compared to both groups of control animals. Portal flow and portal venous inflow were significantly reduced in the presence of overt tumour but hepatic arterial flow did not alter. These observations suggest that the alteration in the HPI in the presence of overt tumour results from an alteration in portal venous flow and inflow even though the blood supply to the tumour is principally derived from the hepatic artery. The changes in hepatic haemodynamics in the presence of tumour were accompanied by a reduction in portal pressure, an increase in splanchnic vascular resistance and an increase in the degree of arteriovenous shunting through the liver. Portal vascular resistance was unchanged. These findings indicate that the presence of overt hepatic tumour results in gross derangements of hepatic blood flow. These changes must be taken into consideration when attempting to potentiate the delivery of cytotoxic drugs to hepatic tumour by manipulation of hepatic haemodynamics.
The hepatic perfusion index (HPI) , that is the ratio of hepatic arterial to total hepatic blood flow determined by dynamic scintigraphy is elevated in the presence of overt tumour in man (Leveson et al., 1983) . Previous studies have suggested that the blood supply to overt liver tumour is derived principally from the hepatic artery (Taylor et al., 1979) . Consequently, it has been assumed that the elevations in the HPI in patients with overt hepatic metastases is related to increases in hepatic artery flow per se. However, this hypothesis cannot be substantiated in man because of the technical difficulties in accurately measuring the various components of hepatic haemodynamics. Therefore, the aim of this study was to establish the changes in hepatic haemodynamics responsible for alterations in the HPI in rats with overt hepatic tumour derived from the intraportal injection of Walker carcinosarcoma cells.
Materials and methods

Inducation of metastases
Walker 256 carcinosarcoma cells were grown in suspension in Williams E Medium (Flow Laboratories Ltd., Rickmans- worth, UK) supplemented with 5% foetal calf serum at 37'C in a 5% CO2 humidified atmosphere. Ninety male Fisher rats approximately 300 g in weight were anaesthetised with intraperitoneal sodium pentobarbitone (6 mg 100 g-' body weight) and the portal vein exposed through a midline incision. Thirty rats received an intraportal inoculation of 1.6 x 107 Walker carcinosarcoma cells in a volume of 0.2 ml, over a period of 10 s using a 2FG gauge needle. Radionuclide studies Ten rats injected intraportally with either viable Walker cells or the same number of dead Walker cells and ten rats receiving saline were anaesthetised with intraperitoneal sodium pentobarbitone and the right common carotid artery exposed through a midline cervical incision. A 10 cm length 2FG polyethylene cannula was introduced into the carotid artery via an arteriotomy. The cannula was screened into position in the left ventricle using a Siemens Siremobile (Siemens Ltd., Sunbury-on-Thames, UK) image intensifier such that its tip was approximately 1 mm below the aortic valve. Adequate expulsion of a small bolus of injectate by the left ventricle was confirmed by injecting 0.1 ml Sodium Meglumine via the cannula. The rats were then placed under an N.E.8900 Gamma camera (Nuclear Enterprises Ltd., Edinburgh, UK) with a 1 cm pinhole collimator linked to a PDP DEK computer (Digital Equipment Corporation, Maynard, Massachusetts, USA). 9'9Tc sulphur colloid (0.04 ml) with an activity of 80 MBq was injected rapidly as a bolus into the left ventricle using a 50 tl High Pressure Liquid Chromatography syringe. Images were acquired at three frames per second and stored on hard disc for subsequent analysis. A compositie image of the first five frames of each study was constructed and regions of interest (ROI) were drawn arqund the left ventricle, right kidney and right lobe of the liver as previously described in detail (Nott et al., 1989 ).
Time activity curves were then generated from these ROIs and each curve was subjected to a maximum of three quadratic smooths. In first pass studies it is assumed that the bolus of radioisotope reaches the hepatic artery and the renal artery at the same time. Therefore the hepatic arterial phase was taken to begin at the start of the kidney arterial phase and extended to the peak of the kidney time activity curve. The portal phase was taken to begin at the peak of the kidney curve and end at the point of recirculation as previously described in detail (Nott et al., 1989 Corrected hepatic arterial flow The development of overt tumour in rats receiving viable tumour cells may underestimate hepatic arterial flow as a result of microspheres passing via arteriovenous shunts from the liver to the lung. The possible source of error was corrected for by using the formula: Corrected Hepatic Arterial Flow (HAFc)= Liver blood flow (ml min -)+ lung blood flow (ml min') -mean lung blood flow in control rats (ml min-1). (2) Ten rats injected intraportally with either dead Walker cells or saline were anaesthetised with intraperitoneal sodium pentobarbitone. Through a midline incision the coeliac, hepatic, gastroduodenal and pancreaticoduodenal arteries were exposed.
The distal gastroduodenal artery was ligated with 7/0 silk at its junction with the pancreaticoduodenal artery. A 10 cm long 2 Fr Portex cannula was inserted via an arteriotomy in the gastroduodenal artery and carefully positioned so that its tip lay just distal to the origin of the coeliac and hepatic arteries. A sodium iodide scintillation counter linked to a scalar ratemeter and computer, was placed over the rat's thorax and screened from the abdomen by a lead screen. Under direct vision using an operating microscope 0.05 ml of 9'Tc methylene diphosphonate (9Tc-MDP) was injected via the hepatic artery cannula over 10 s at physiological pressures (using a high pressure liquid chromatography syringe). The amount of radioactivity passing to the lungs was measured by the scintillation counter. Since 9"Tc-MDP is not retained within the liver, the majority passes to the lungs and is registered graphically by the computer as a 100% passing fraction. The 99"Tc-MDP therefore acts as a reference injection. Following administration of the 9'Tc-MDP, 0.05 ml 99mTc-macroaggragated albumen (99'Tc-MAA) mean diameter 25 microns (range 15-35 microns) were administered via the cannula using a high pressure liquid chromatography syringe over l0 s. Unlike 991Tc-MDP, macroaggregated albumen is trapped within the liver sinusoids and only those particles passing through the liver via arteriovenous shunts appear in the lung field of interest. The percentage passing fraction of 99"Tc-MAA passing through the liver is represented as a percentage of the passing fraction of the reference injection of 99mTc-MDP. Previous studies have indicated an excellent correlation (r = 0.94) between this method of measuring intrahepatic arteriovenous shunting and that evaluated by the more classical method using microspheres.
Statistical anaysis
Results are expressed as the mean ± s.d. Statistical differences in hepatic haemodynamics between the rats with overt tumour and control animals were evaluated using a Mann Whitney U test.
Results
Tumour weight All rats injected with Walker cells developed overt tumour during the 3 weeks experimental period. However, there was a wide variation in the number (14-26) size, and weight of the tumour between individual rats (6.48 ± 2.44 g, Mean ± s.d. range 1.93-10.11 g). Rats injected with dead Walker cells did not develop any hepatic tumour.
Hepatic perfusion index
The hepatic perfusion index in control rats was significantly less (P<0.01) than those with overt tumour (Figure 1 ).
Changes in hepatic haemodynamics
The hepatic arterial blood flow and the corrected hepatic arterial blood flow were not significantly different between rats with overt tumour and controls measured by either electromagnetic flowmetry or the microsphere technique. In contrast, portal venous inflow (microspheres) and portal flow (electromagnetic flowmetry) were significantly reduced (P<0.001) in rats with overt tumour compared to controls. Although there was no significant difference in cardiac output between the two groups, lung blood flow was significantly increased in rats with overt tumour compared to controls (P<0.02) ( Table I) .
The reduction in portal venous flow in rats with overt tumour was accompanied by a reduction in portal pressure. Consequently, there was no significant difference in portal vascular resistance between rats with tumour and control rats. Conversely, splanchnic vascular resistance was significantly increased in rats with overt tumour compared to controls (Table II) The results are expressed as mean + I Standard Deviation. Asterisks denote a significant difference between the two groups of animals: ***P < 0.001; **P < 0.02; *P = 0.05 (Mann Whitney U test). The results are expressed as mean + 1 Standard Deviation. Asterisks denote a significant difference between the two groups of animals: ***P < 0.001; **P < 0.02; *P + 0.05 (Mann Whitney U test).
Tumour:liver ratio
The tumour:liver ratio of cobalt microspheres was 1.18 + 0.18.
Intrahepatic shunting
Following intraventricular administration of the microspheres there was a significant increase (P<0.001) in the lung:liver ratio of 57Co in rats with overt tumour (0.36 + 0.11) compared to control rates (0.22 + 0.07) indicative of increased intrahepatic arteriovenous shunting. similarly, the passage of 9'Tc-MAA was significantly higher in rats with overt tumour than control rats (Figure 2 ).
Discussion
The results of this study confirm previous observations in man that the HPI determined by dynamic scintigraphy is altered in the presence of hepatic tumours (Leveson et al., 1985) . There was no correlation between the size of the tumours and changes in the HPI. Indeed the elevations in the HPI were of a similar magnitude to those observed in rats with micrometastatic tumour derived from intraportal administration of Walker cells (Nott et al., 1989) . Furthermore, our results support previous suggestions that the blood supply to hepatic tumour tissue is principally derived from the hepatic artery (Taylor et al., 1979) . The increase in the HPI in the presence of overt liver tumour is not however related to the changes in the hepatic arterial flow per se as was previously suggested (Leveson et al., 1985) (Nott et al., 1989 (unpublished) .
The presence of overt hepatic tumour in the rat was accompanied by a marked increase in arteriovenous shunting as evidenced by an increased passage of "Co and 99nTc-MAA through the liver. These observations are therefore in accord with a previous observation which also indicated the presence of intrahepatic arteriovenous shunts assoicated with liver metastases derived from colorectal carcinoma in man (Starkhammer et al., 1987 ). The precise nature of these intrahepatic arteriovenous anastomoses is not known, but they could arise from the 'opening up' of pre-existing shunts. Alternatively shunts could develop de novo within or around the tumour. Nevertheless, the existance of arteriovenous shunts in the presence of overt tumour may explain why regional chemotherapy via the hepatic artery appears to have a marginal therapeutic effect, since a large proportion of the cytotoxic may be shunted around or through the tumour.
In summary therefore, the results of this study indicate that overt tumour derived from the intraportal inoculation of Walker cells results in an increase in the HPI. The blood supply to the tumour is derived principally from the hepatic artery. However hepatic arterial flow does not change in the presence of tumour and the alterations in the HPI are secondary to a reduction in portal venous inflow. Moreover, the presence of overt hepatic tumour is associated with gross derangement of hepatic haemodynamic with a pronounced increase in intrahepatic arteriovenous shunting. The haemodynamic changes accompanying the development of overt hepatic tumour are complex and must be taken into account when attempting to potentiate the distribution of cytotoxics to the tumour by regional administration or through manipulation of liver blood flow.
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